HIF1A and neoplasm: To further validate that L-2-HG promotes HIF1A expression and inhibits ferroptosis to promote the malignant phenotype of tumor cells, cells were treated with the ferroptosis inhibitor deferoxamine (DFO) during HIF1A knockdown.